TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17702837

Group type: EXPERIMENTAL
Intervention: Infusion of [(13)C]bicarbonate during exercise at 45% Vo(2peak)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Infusion of [(13)C]bicarbonate during exercise at 65% Vo(2peak)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Resting control trial
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Postexercise recovery at 45% Vo(2peak)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Postexercise recovery at 65% Vo(2peak)
Number of subjects: 19
Study: 16380390

Group type: EXPERIMENTAL
Intervention: Hypocaloric group (HYPO) at sea level
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Deficient group (DEF) at 4,300 meters
Number of subjects: 26

Group type: COMPARATOR
Intervention: Adequately fed group (ADQ) at 4,300 meters
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both altitude groups (ADQ and DEF)
Number of subjects: 26
Study: 15560830

Group type: EXPERIMENTAL
Intervention: Holding the drink in the mouth before swallowing
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Long-sipping method
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Gulping
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Telemetric method
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Microtouch method
Number of subjects: 18
Study: 10797401

Group type: EXPERIMENTAL
Intervention: Strength training with heavy loads
Number of subjects: 13

Group type: COMPARATOR
Intervention: Strength training with light loads
Number of subjects: 13

Group type: COMPARATOR
Intervention: No training (control group)
Number of subjects: 13
Study: 8970411

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (0.625 mg/day conjugated estrogens or 2 mg/day estradiol)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (nonusers)
Number of subjects: 30
Study: 1455880

Group type: EXPERIMENTAL
Intervention: Pre-operative chemotherapy (cisplatin and bleomycin) and surgery
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Pre-operative irradiation (35 Gy) and surgery
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Pre-operative chemotherapy, radiotherapy, and surgery
Number of subjects: 186

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 186
Study: 6380905

Group type: EXPERIMENTAL
Intervention: Metoprolol (100-200 mg daily)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Methyldopa (500-1000 mg daily)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 31331237

Group type: EXPERIMENTAL
Intervention: V#V sequences
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High first vowel in V#V sequences
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-high first vowel in V#V sequences
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diphthongs
Number of subjects: 0
Study: 28612330

Group type: EXPERIMENTAL
Intervention: Mitomycin C (MMC) applied after PRK for 5 seconds for each diopter of spherical equivalent myopic refractive error corrected.
Number of subjects: 48
Study: 28699324

Group type: EXPERIMENTAL
Intervention: Cataract surgery followed by 23-gauge pars plana vitrectomy (PPV)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: PPV followed by cataract surgery
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Combined phacovitrectomy (PPV and cataract surgery simultaneously)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Combined phacovitrectomy (COMBI group)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Cataract surgery and PPV (all groups)
Number of subjects: 62
Study: 25432505

Group type: EXPERIMENTAL
Intervention: Fundamental motor skill intervention
Number of subjects: 9

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Combined groups (experimental and control)
Number of subjects: 9
Study: 23270318

Group type: EXPERIMENTAL
Intervention: Acupuncture on Yintang point
Number of subjects: 52

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 52
Study: 21571234

Group type: EXPERIMENTAL
Intervention: Emotional Freedom Techniques (EFT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Diaphragmatic breathing
Number of subjects: 22
Study: 18563389

Group type: EXPERIMENTAL
Intervention: Half-molar sodium-lactate (HL) solution, 10 ml kg BW(‐1) over 12 hours
Number of subjects: 208

Group type: COMPARATOR
Intervention: Ringer's lactate (RL) solution, 30 ml kg BW(‐1) over 12 hours
Number of subjects: 208
Study: 16847538

Group type: EXPERIMENTAL
Intervention: Alcohol dependence only
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Comorbid alcohol dependence and PTSD
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: PTSD without alcohol dependence
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 119
Study: 12673136

Group type: EXPERIMENTAL
Intervention: Exercise group (1 yr resistance training, 60-75 min.d-1, 3 d.wk-1)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Nonexercise group (no intervention)
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Total weight lifted in training sessions
Number of subjects: 233
Study: 10907144

Group type: EXPERIMENTAL
Intervention: Older couples presenting for conjoint therapy
Number of subjects: 3

Group type: COMPARATOR
Intervention: Younger couples presenting for conjoint therapy
Number of subjects: 3
Study: 8799414

Group type: EXPERIMENTAL
Intervention: Locoregional immunochemotherapy (Group B)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard operative procedure (Group A)
Number of subjects: 80
Study: 1535447

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (0.5 mg nebulized)
Number of subjects: 16
Study: 6146861

Group type: EXPERIMENTAL
Intervention: Oral cyclophosphamide 80 mg/m2 on days 1‐14, intravenous methotrexate 32 mg/m2 on days 1 and 8, and intravenous fluorouracil 480 mg/m2 on days 1 and 8 (CMF), repeated every 28 days for twelve cycles.
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: CMF treatment
Number of subjects: 327

Group type: COMPARATOR
Intervention: Control group (no additional treatment)
Number of subjects: 327
Study: 31799940

Group type: EXPERIMENTAL
Intervention: Patient Decision Aid
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 120
Study: 28364419

Group type: EXPERIMENTAL
Intervention: Modafinil treatment during abstinence
Number of subjects: 43
Study: 27185725

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 μg/kg IV infusion
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Labetalol 0.25 mg/kg IV
Number of subjects: 90

Group type: COMPARATOR
Intervention: Saline 10 mL IV
Number of subjects: 90
Study: 24376009

Group type: EXPERIMENTAL
Intervention: Severe obesity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moderate obesity
Number of subjects: 0
Study: 21971575

Group type: COMPARATOR
Intervention: Alendronate 70 mg orally, once weekly
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (IMN) 40 mg orally once daily
Number of subjects: 90
Study: 19540138

Group type: EXPERIMENTAL
Intervention: General anaesthesia (GA)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Local anaesthesia (LA)
Number of subjects: 27
Study: 17556722

Group type: EXPERIMENTAL
Intervention: Prophylactic heparin
Number of subjects: 1994

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 1994
Study: 14672887

Group type: EXPERIMENTAL
Intervention: Occupational Therapy (OT)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Control
Number of subjects: 326
Study: 11137832

Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg/day)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Fenofibrate (200 mg/day)
Number of subjects: 13
Study: 9439404

Group type: EXPERIMENTAL
Intervention: Sterile water
Number of subjects: 50

Group type: COMPARATOR
Intervention: 1.5% glycine
Number of subjects: 50
Study: 8339624

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (10 mg/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 3789327

Group type: EXPERIMENTAL
Intervention: Terbutaline slow-release tablets (Bricanyl Depot), 5 mg twice daily
Number of subjects: 10

Group type: COMPARATOR
Intervention: Terbutaline ordinary tablets (Bricanyl), 2.5 mg three times daily
Number of subjects: 10
Study: 31469776

Group type: EXPERIMENTAL
Intervention: AS04-adjuvanted HPV-16/18 vaccine (2-dose schedule)
Number of subjects: 74
Study: 28912305

Group type: EXPERIMENTAL
Intervention: Liraglutide (1.8 mg/day)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Lifestyle counseling
Number of subjects: 62
Study: 26907917

Group type: EXPERIMENTAL
Intervention: Passive-scattering proton therapy (PT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intensity modulated radiation therapy (IMRT)
Number of subjects: 20
Study: 24519012

Group type: EXPERIMENTAL
Intervention: 0.8 g/kg of alcohol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (0 g/kg)
Number of subjects: 30
Study: 23000125

Group type: EXPERIMENTAL
Intervention: LAIV
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19393843

Group type: EXPERIMENTAL
Intervention: BUP infusion (0.4 microg/kg/h) + BUP boluses (0.15 microg/kg)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: MO infusion (10 microg/kg/h) + MO boluses (5 microg/kg)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: BUP infusion (0.4 microg/kg/h) + MO boluses (5 microg/kg)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: MO infusion (10 microg/kg/h) + BUP boluses (0.15 microg/kg)
Number of subjects: 120
Study: 17613395

Group type: EXPERIMENTAL
Intervention: Everolimus (ERL)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Azathioprine (AZA)
Number of subjects: 34
Study: 15135473

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node (SLN) biopsy using Patent blue V and 99mTc-radiolabelled colloidal albumin
Number of subjects: 9

Group type: COMPARATOR
Intervention: Axillary lymph node dissection (ALND)
Number of subjects: 9
Study: 11818011

Group type: EXPERIMENTAL
Intervention: Noninvasive total hemoglobin measurement using a five-wavelength light emitting diode array
Number of subjects: 129
Study: 9882760

Group type: EXPERIMENTAL
Intervention: Melatonin (5 mg p.o.)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Temazepam (20 mg p.o.)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 7721974

Group type: EXPERIMENTAL
Intervention: 0.15 mg nitroglycerin (LDG)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.3 mg nitroglycerin (HDG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 20
Study: 2199853

Group type: EXPERIMENTAL
Intervention: Ciclopiroxolamine globules, 100 mg nightly for six days
Number of subjects: 46

Group type: COMPARATOR
Intervention: Clotrimazole vaginal tablets, 200 mg nightly for six days
Number of subjects: 46
Study: 7014121

Group type: EXPERIMENTAL
Intervention: Oral propranolol, 40 mg
Number of subjects: 13

Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 13
Study: 31036037

Group type: EXPERIMENTAL
Intervention: Interdisciplinary education and usual care
Number of subjects: 20

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 20
Study: 28431191

Group type: EXPERIMENTAL
Intervention: Early cycled light (ECL) starting at 28 weeks postmenstrual age (PMA)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Late cycled light (LCL) starting at 36 weeks PMA
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Early cycled light (ECL)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Late cycled light (LCL)
Number of subjects: 118
Study: 25212414

Group type: EXPERIMENTAL
Intervention: PDA training at the beginning of job placement
Number of subjects: 50

Group type: COMPARATOR
Intervention: PDA training after 12 weeks without PDA support
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups using a PDA
Number of subjects: 50
Study: 24220165

Group type: EXPERIMENTAL
Intervention: Rice fortified with iron (Ultrarice®)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Standard household rice (control)
Number of subjects: 171
Study: 21608223

Group type: EXPERIMENTAL
Intervention: Blood activating and stasis removing herbs
Number of subjects: 141

Group type: COMPARATOR
Intervention: Blood cooling and arresting herbs
Number of subjects: 141
Study: 19910803

Group type: EXPERIMENTAL
Intervention: Balance training program (at least 10 minutes per day, 3 days per week, for 4 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Balance training program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Various methods of balance training (including tilt boards, unstable surfaces, and dynamic body movements)
Number of subjects: 0
Study: 17432396

Group type: EXPERIMENTAL
Intervention: Restored teeth with Syntac Single adhesive and Tetric Ceram composite under 150 N load
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Restored teeth with Syntac Single adhesive and Tetric Ceram composite
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unaltered teeth under 150 N load
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unaltered teeth (baseline condition)
Number of subjects: 20
Study: 12772743

Group type: EXPERIMENTAL
Intervention: Silicone hydrogel lenses (Focus NIGHT & DAY, Focus DAILIES)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Conventional hydrogels (ACUVUE 2, Proclear Compatibles)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Symptomatic group
Number of subjects: 39
Study: 11006450

Group type: EXPERIMENTAL
Intervention: Ceftibuten 9 mg/kg/day for 5 days
Number of subjects: 180

Group type: COMPARATOR
Intervention: Ceftibuten 9 mg/kg/day for 10 days
Number of subjects: 180
Study: 8839497

Group type: EXPERIMENTAL
Intervention: Cereal-based precooked porridge offered twice daily for 3 months (558-790 kJ/d)
Number of subjects: 447

Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 447
Study: 1427411

Group type: EXPERIMENTAL
Intervention: Serum progesterone (P) levels in ectopic pregnancy (EP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 17-hydroxyprogesterone (17-OHP) levels in ectopic pregnancy (EP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serum progesterone (P) levels in intrauterine pregnancies (IUP)
Number of subjects: 0
Study: 6436891

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 195 mg caffeine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 325 mg caffeine
Number of subjects: 24
Study: 3555083

Group type: EXPERIMENTAL
Intervention: 10 IU of oxytocin in 10 ml of sodium chloride into the umbilical vein
Number of subjects: 51

Group type: COMPARATOR
Intervention: 10 ml of sodium chloride
Number of subjects: 51

Group type: COMPARATOR
Intervention: Manual removal of the placenta
Number of subjects: 51
Study: 29246417

Group type: EXPERIMENTAL
Intervention: Incision and Drainage (I&D) with drain placement
Number of subjects: 81

Group type: COMPARATOR
Intervention: Mock I&D procedure with mock drain placement
Number of subjects: 81
Study: 26724798

Group type: EXPERIMENTAL
Intervention: CryotopSC device
Number of subjects: 48

Group type: COMPARATOR
Intervention: CBSvit device
Number of subjects: 48
Study: 24048623

Group type: EXPERIMENTAL
Intervention: Unsupervised reading and exploration training (35 hours)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control training (35 hours)
Number of subjects: 70
Study: 23412078

Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 20138301

Group type: EXPERIMENTAL
Intervention: Budesonide + surfactant (every 8 hours)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Budesonide + surfactant
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control (surfactant only)
Number of subjects: 67
Study: 18407876

Group type: EXPERIMENTAL
Intervention: Individual Placement and Support (IPS)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control
Number of subjects: 11
Study: 17081363

Group type: EXPERIMENTAL
Intervention: Probucol (n = 24)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Standard therapy (Control, n = 25)
Number of subjects: 49
Study: 12823568

Group type: EXPERIMENTAL
Intervention: Monotherapy with antiepileptic drugs (AEDs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapeutic drug monitoring for dosage tailoring
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Newer antiepileptic agents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Evidence-based medicine and treatment guidelines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patient-tailored AED selection and dose individualization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy in refractory epilepsies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel antiepileptic drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exploration of new targets for prevention of epileptogenesis
Number of subjects: 0
Study: 10917409

Group type: EXPERIMENTAL
Intervention: R(+)‐nicotine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: S(‐)‐nicotine
Number of subjects: 30

Group type: COMPARATOR
Intervention: S(‐)‐nicotine at trigeminal concentrations
Number of subjects: 30
Study: 9151592

Group type: EXPERIMENTAL
Intervention: e-PTFE membrane with biomaterial (DFDBA or Bio Oss)
Number of subjects: 12

Group type: COMPARATOR
Intervention: e-PTFE membrane without biomaterial
Number of subjects: 12
Study: 1430302

Group type: EXPERIMENTAL
Intervention: Encainide with food
Number of subjects: 14

Group type: COMPARATOR
Intervention: Encainide after fasting
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Food effect on O-demethyl-encainide (ODE)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Food effect on methoxy-O-demethyl-encainide (MODE)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Surface electrocardiogram 2 hours after dose administration
Number of subjects: 14
Study: 3973042

Group type: EXPERIMENTAL
Intervention: Instructions to report distress and personal problems (Study 1)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: R-S scale scores (Study 2)
Number of subjects: 142
Study: 30638262

Group type: EXPERIMENTAL
Intervention: ProRoot MTA
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 69
Study: 29556707

Group type: EXPERIMENTAL
Intervention: Hammock-shaped mini-sling
Number of subjects: 126

Group type: COMPARATOR
Intervention: U-shaped mini-sling
Number of subjects: 126
Study: 27329780

Group type: EXPERIMENTAL
Intervention: Topical natamycin
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Topical voriconazole
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Pretreatment with antifungal agents
Number of subjects: 323
Study: 25010608

Group type: EXPERIMENTAL
Intervention: Triple-dose albendazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trichuris trichiura-infected children
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Children with low-intensity T. trichiura and hookworm infections
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Children infected with hookworm and Ascaris lumbricoides
Number of subjects: 0
Study: 22202581

Group type: EXPERIMENTAL
Intervention: Whole-cell melanoma vaccine (Canvaxin) plus Bacille Calmette-Guerin (BCG)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Placebo plus Bacille Calmette-Guerin (BCG)
Number of subjects: 244
Study: 20860537

Group type: EXPERIMENTAL
Intervention: Extra water intake (EWI, an additional 30 ml water/kg body weight per day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Regular water intake (RWI)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Extra water intake (EWI)
Number of subjects: 20
Study: 17905800

Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 65
Study: 15681320

Group type: EXPERIMENTAL
Intervention: Gadolinium-enhanced volumetric MRI
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 0
Study: 12525733

Group type: EXPERIMENTAL
Intervention: ALS subjects
Number of subjects: 25
Study: 10891628

Group type: EXPERIMENTAL
Intervention: Clozapine 12.5 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Clozapine 25 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Clozapine 50 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 8
Study: 8752234

Group type: EXPERIMENTAL
Intervention: Atosiban (0.6 mg plus 30 micrograms/minute)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Atosiban (6.5 mg bolus plus 300 micrograms/minute)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Ritodrine
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Atosiban (other regimens)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Atosiban (overall)
Number of subjects: 302
Study: 1362394

Group type: EXPERIMENTAL
Intervention: levodopa
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: dopamine agonists
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: l-deprenyl
Number of subjects: 475
Study: 3891617

Group type: EXPERIMENTAL
Intervention: Captopril (50 mg oral)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 31427349

Group type: EXPERIMENTAL
Intervention: Acupuncture for chronic neck pain
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 29495529

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 27167210

Group type: EXPERIMENTAL
Intervention: Nasal CPAP at 10 cm H2O
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Nasal CPAP at 1.5 cm H2O
Number of subjects: 26

Group type: COMPARATOR
Intervention: Baseline (no CPAP)
Number of subjects: 26
Study: 24127698

Group type: EXPERIMENTAL
Intervention: Cognitive training (CT) program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 0
Study: 22397811

Group type: EXPERIMENTAL
Intervention: Reduced-salt label
Number of subjects: 50

Group type: COMPARATOR
Intervention: No health label
Number of subjects: 50

Group type: COMPARATOR
Intervention: Heart Foundation Tick
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Soups with 15% less sodium
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Soups with 30% less sodium
Number of subjects: 50

Group type: COMPARATOR
Intervention: Soups without health labels
Number of subjects: 50